Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an update.
Recordati S.p.A. has provided an update on its share buyback program, which began on April 30, 2025, following a resolution by the Shareholders’ Meeting. The program aims to purchase shares for stock options and performance share plans for the company’s management. Between August 18 and 22, 2025, Recordati purchased 38,121 ordinary shares at an average price of 52.1938 Euros per share. As of August 22, 2025, Recordati holds 4,149,013 own shares, representing 1.984% of its share capital.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR57.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, originating from a family-run pharmacy in Northern Italy in the 1920s. The company offers therapeutic options in general and specialist medicine and rare diseases, with operations spanning clinical development, production, marketing, and licensing of active ingredients and finished products. Recordati operates in approximately 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people globally.
Average Trading Volume: 251,425
Technical Sentiment Signal: Buy
Current Market Cap: €10.79B
For a thorough assessment of REC stock, go to TipRanks’ Stock Analysis page.